Barbara Harlin Bispham sold $11K of Crescent Biopharma, Inc. (CBIO) stock

Barbara Harlin Bispham sold 620 shares of CBIO stock worth $11K, per an SEC Form 4 filed Sep 18, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 16, 2026, 2 days before it was made public.

CBIO has moved -4.3% since the trade date, from $17.18 to $16.44 (Sep 22, 2026 close).